1.諶貽璞，程虹.肥胖相關性腎小球病//諶貽璞.腎內科學.北京：人民衛生出版社，2008：87-97.

2. Weisinger JR，Kempson RL，Eldridge FL，et al. The nephrotic syndrome：a complication of massive obesity.Ann Intern Med，1974，81（4）：440-447.

3. Kambham N，Markowitz GS，Valeri AM，et al.Obesity-related glomerulopathy：An emerging epidemic.Kidney Int，2001，59：1498-1509.

4.程虹，諶貽璞，張聰，等.比較兩種肥胖相關性腎小球病的臨床-病理特點.中華腎臟病雜志.2009，25：261-264.

5.董葆，陳文，程虹，等.肥胖相關性局灶節段性腎小球硬化癥臨床與病理表現.中華腎臟病雜志，2002，18：389-392.

6. Chen HM，Li SJ，Chen HP，et al.Obesity-related glomerulopathy in China：a case series of 90 patients.Am J Kidney Dis，2008，52（1）：58-65.

7. Praga M，Hernandez E，Morales E，et al.Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.Nephrol Dial Transplant，2001，16：1790-1798.

8. Adelman RD，Restaino IG，Alon US，et al.Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents.J Pediatr，2001，138（4）：481-485.

9. Ritz E，Kolgeganova T，Piecha G.Is there an obesity-metabolic syndrome related glomerulopathy？Curr Opin Nephrol Hypertens，2011，20（1）：44-49.

10. Serra A，Romero R，Lopez D，et al.Renal injury in the extremely obese patients with normal renal function.Kidney Int，2008，73（8）：947-955.

11. Darouich S，Goucha R，Jaafoura MH，et al.Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.Ultrastruct Pathol，2011，35（4）：176-182.

12. Agarwal R，Bills JE，Light RP.Diagnosing obesity by body mass index in chronic kidney disease：an explanation for the“obesity paradox？”.Hypertension，2010，56（5）：893-900.

13. Burton JO，Gray LJ，Webb DR，et al.Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population.Nephrol Dial Transplant，2012，27（5）：1860-1866.

14. Ibrahim MM.Subcutaneous and visceral adipose tissue：structural and functional differences.Obes Rev，2010，11 （1）：11-18.

15. Chen H，Liu Z，Li S，et al.The relationship between body fat distribution and renal damage in Chinese with obesity. Exp Clin Endocrinol Diabetes，2008，116（2）：99-103.

16. Ashwell M，Gunn P，Gibson S.Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors：systematic review and meta-analysis.Obes Rev，2012，13（3）：275-286.

17. Lane PH，Steffes MW，Mauer SM.Estimation of glomerular volume：a comparison of four methods. Kidney Int，1992，41：1085-1089.

18. Cheng H，Dong HR，Lin RQ，et al.Determination of normal value of glomerular size in Chinese adults by different measurement methods.Nephrology，2012，17（5）：488-492.

19. Moore L，Lloyd MS，Pugsley DJ，et al.Renal disease in the Australian Aboriginal population：A pathological study.Nephrology，1996，2：315-321.

20. Chen HM，Liu ZH，Zeng CH，et al.Podocyte lesions in patients with obesity-related glomerulopathy Am J Kidney Dis，2006，48（5）：772-779.

21. Camici M，Galetta F，Abraham N，et al. Obesity-related glomerulopathy and podocyte injury：a mini review.Front Biosci（Elite Ed），2012，4：1058-1070.

22. Wolf G，Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol，2006，151：175-183.

23. Hunley TE，Ma LJ，Kon V. Scope and mechanisms of obesity-related renal disease.Curr Opin Nephrol Hypertens，2010，19（3）：227-234.

24. Ballantyne GH，Gumbs A，Modlin IM.Changes in insulin resistance following bariatric surgery and the adipoinsular axis：role of the adipocytokines，leptin，adiponectin and resistin.Obes Surg，2005，15（5）：692-699.

25. Ehrhart-Bornstein M，Lamounier-Zepter V，Schraven A，et al.Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A，2003，100：14211-14216.

26. Kiyomoto H，Rafiq K，Mostofa M，et al.Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J Pharmacol Sci，2008，108（4）：399-405.

27.唐功耀，楊敏，諶貽璞，等.脂聯素在人腎小球微血管內皮細胞中的表達與調節.中華醫學雜志，2010，90 （9）：633-637.

28. Lee SH，Yoo TH，Nam BY，et al.Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.Am J Physiol Renal Physiol，2009，297：1381-1390.

29. Chen HM，Chen Y，Zhang YD，et al.Evaluation of metabolic risk marker in obesity-related glomerulopathy.J Ren Nutr，2011，21（4）：309-315.

30. Kiortsis DN，Christou MA.Management of obesity-induced kidney disease：A critical review of the Literature.Obes Facts，2012，5（6）：821-832.

31. Shen WW，Chen HM，Chen H，et al.Obesity-related glomerulopathy：body mass index and proteinuria.Clin J Am Soc Nephrol，2010，5（8）：1401-1409.

32. Navarro-Díaz M，Serra A，Romero R，et al.Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients：long-term follow-up.J Am Soc Nephrol，2006，17（12 Suppl 3）：S213-S217.

33. Rucker D，Padwal R，Li SK，et al.Long term pharmacotherapy for obesity and overweight：updated meta-analysis.BMJ，2007，335（7631）：1194-1199.

34. Sarafidis PA，Bakris GL.Protection of the kidney by thiazolidinediones：an assessment from bench to bedside.Kidney Int，2006，70（7）：1223-1233.

35. Tanner RM，Brown TM，Muntner P.Epidemiology of obesity，the metabolic syndrome，and chronic kidney disease. Curr Hypertens Rep，2012，14（2）：152-159.